S&P 500 7,707.98 +0.21%Nasdaq 26,331.09 +0.16%Dow 53,463.05 +0.22%Russell 2000 3,032.94 +0.50%as of 2026-08-19 close
The SmallCap Signal
Small & mid-cap intelligence for the next market cycle
Small Caps

Quantum Corporation Booked a $155.3 Million Loss on 22 Million Shares. It Had 39.4 Million by August.

The data-storage company's fiscal first-quarter 10-Q shows a $5.0 million operating profit sitting above a $155.3 million net loss. Three fair-value and extinguishment charges tied to June's debt-for-equity recapitalization account for $157.7 million, and the cash flow statement treats all but about $3.3 million of them as non-cash. The per-share figure is struck on a weighted-average count barely half the shares outstanding on August 6, and the September quarter is the first that will carry the new count for its full length.
Quantum Corporation Booked a $155.3 Million Loss on 22 Million Shares. It Had 39.4 Million by August.

Quantum Corporation, the maker of tape libraries, backup appliances and object-storage software that trades on the Nasdaq Global Market as QMCO, put out its fiscal first-quarter earnings release at 4:05 p.m. Eastern on August 10 and submitted the matching quarterly report to EDGAR the same evening; because the submission arrived after the system's late-afternoon cut-off, the 10-Q carries an August 11 filing date. The headline in that report is a net loss of $155,293 thousand, or $(7.06) a share, basic and diluted. Higher up the same statement of operations is income from operations of $5,038 thousand, against a loss from operations of $12,596 thousand in the comparable quarter a year earlier. Both numbers are in the same filing, and the distance between them is the story. The company should not be confused with the several quantum-computing issuers that share a piece of its name; this Quantum sells storage hardware and software, and the 10-Q cover page gives its principal executive offices as Centennial, Colorado.

The bridge from a $5.0 million operating profit to a $155.3 million net loss runs through the non-operating section, and three of its lines are consequences of a debt restructuring the company completed in early June. Below operating income the statement of operations shows other income of $211 thousand, interest expense of $(2,097) thousand, a change in the fair value of warrant liabilities of $(16,305) thousand, a change in the fair value of the convertible note of $(129,715) thousand, and a net loss on debt extinguishment of $(11,716) thousand. All three of the restructuring lines are charges, not credits; the extinguishment line was a $2,559 thousand gain a year earlier, and the two fair-value lines had no prior-year comparative at all. Run the arithmetic and it ties: operating income plus other income less those four charges comes to the loss before income taxes of $(154,583) thousand that the filing reports, to within a thousand dollars of rounding, and an income tax provision of $710 thousand carries it to the $155,293 thousand net loss. The three restructuring charges sum to $157,736 thousand — more than the whole gap, because the operating profit absorbs part of them.

Two of those three charges moved no cash at all, and the third moved only part of the way. The condensed consolidated statement of cash flows carries the $129,715 thousand convertible-note remeasurement and the $16,305 thousand warrant remeasurement in full among the operating-section adjustments that reconcile net loss to cash. The extinguishment loss appears there too, but only as $8,372 thousand of "non-cash loss (gain) on debt extinguishment" — the remaining roughly $3.3 million of the income-statement charge is not classified as non-cash.

The convertible note produced the largest of the three figures because of an accounting election. "The Company elected the fair value option under ASC 825 for the Convertible Note," the 10-Q states, which means the note was carried on the balance sheet at fair value and remeasured each period, with the change running straight through earnings. The note was carried at $90,034 thousand at March 31, 2026. It was carried at zero at June 30.

What happened to it is set out in the filing. On June 1, 2026 Quantum entered into a Conversion Agreement with the noteholder, Dialectic Technology SPV LLC, and a Sixteenth Amendment to its Term Loan Credit Agreement. On June 4, in the filing's words, "Dialectic converted the entire principal amount of the Convertible Note, together with all accrued and unpaid interest thereon, which was approximately $57.2 million" — that figure is principal and interest combined, not principal alone — at a conversion price of $5.1940 per share, and Quantum issued 14,104,620 shares of common stock. Concurrently the company agreed to sell 10,615,712 shares to accredited investors at $9.42 a share "for aggregate gross proceeds to the Company of $100.0 million," from which, after placement agent fees and offering expenses, "the Company received net proceeds of approximately $94.6 million." On June 4 it paid an aggregate of $57.8 million "in connection with the termination of the Term Loan Credit Agreement, consisting of the entire outstanding principal amount, accrued interest, and fees and expenses incurred in connection with the termination." Dialectic also received a Conversion Warrant over 105,911 shares at $5.1940, exercisable until the fifth anniversary of its issuance.

The resale registration statement Quantum filed on July 13 breaks the 14,104,620 shares into two pieces. 11,020,645 came out of converting the note itself. The other 3,083,975 the prospectus calls the Share Consideration, and defines arithmetically: the quotient of approximately $13.0 million — the nominal payment-in-kind interest that would have accrued on the convertible notes from closing through their stated maturity had they stayed outstanding, discounted at 11 percent — plus approximately $3.0 million of deferred cash interest owed to Dialectic under the term loan credit agreement, divided by the $5.1940 conversion price. Roughly $16.0 million of forgone and deferred interest, in other words, was settled in stock struck at $5.1940 on the same day the private placement priced at $9.42.

Add the two June issuances together and you get 24,720,332 new shares in a single quarter. The balance sheet in the 10-Q shows 14,638 thousand shares outstanding at March 31, 2026 and 39,375 thousand at June 30; the two transactions account for all but about 17 thousand of the increase. The cover page of the same filing reports 39,410,001 shares issued and outstanding as of August 6, 2026. The statement of stockholders' deficit puts the equity credited by the conversion at $222,571 thousand and the equity credited by the placement, net of issuance costs, at $94,638 thousand.

Now put that against the denominator the loss was divided by. The weighted-average share count used for the quarter is 21,988 thousand, and the filing uses the same figure for basic and for diluted. That is the arithmetic consequence of adding 24.7 million shares on the sixty-fifth day of a 91-day quarter: the new shares sit in the average for only about four weeks of it, and the average comes out a little over half the count the company actually carries today. The $(7.06) figure is correctly computed under the rules; it is simply computed against a capital structure Quantum no longer has. The company's own non-GAAP presentation has the same property. It reported $3,994 thousand of adjusted net income, or $0.18 per share on a basic and diluted basis alike — a ratio that implies roughly 22 million shares, not 39 million.

For fiscal second-quarter 2027, Quantum guided to revenue of $82.0 million plus or minus $2 million, non-GAAP adjusted operating expenses of $27 million plus or minus $1 million, non-GAAP adjusted basic net income per share of $0.12 plus or minus $0.10, and non-GAAP adjusted EBITDA of $6 million plus or minus $1 million. The release states that per-share metric on a basic basis. That is a narrower label than the quarter just reported, which carried $0.18 on a basic and diluted basis alike — but it is a narrowing of the label, not a switch between two different denominators, and nothing in the release turns on the distinction. What is genuinely different about the September quarter is duration: the recapitalized share count will be outstanding for all of it rather than for its last four weeks.

One illustration, and it is our arithmetic rather than the company's. Multiply the $0.12 midpoint by the 39,410,001 shares on the August 6 cover page and the guide implies something on the order of $4.7 million of adjusted net income, with the guided band running from roughly $0.8 million to roughly $8.7 million. Treat that only as an order of magnitude: the two inputs carry different dates, the company has published no share-count assumption behind the guide, and the actual weighted average for the September quarter is not knowable yet. On that basis the midpoint sits above the $4.0 million of adjusted net income just reported even though the per-share number guided to is a third lower — which is what a roughly doubled denominator does to a per-share figure.

Two other lines in the guide move the other way from the first quarter's result. Adjusted EBITDA of $6 million at the midpoint is below the $7,971 thousand the company reported for the June quarter, and adjusted operating expenses of $27 million at the midpoint are above the $25,139 thousand of adjusted operating expenses in the release. Revenue at the midpoint is up about 1.5 percent sequentially.

The balance-sheet effect of the June transactions runs the opposite direction from the income statement, which is the point the headline loss obscures. Total stockholders' deficit narrowed to $27,825 thousand at June 30 from $198,857 thousand at March 31 — an improvement of $171.0 million in a quarter that recorded a $155.3 million loss. The conversion and the placement credited equity by more than the loss took out of it. Cash and cash equivalents rose to $54,449 thousand from $15,572 thousand at March 31. Operating activities generated $947 thousand of cash in the quarter, against $16,891 thousand consumed a year earlier. The earnings release states that total outstanding debt is zero "as a result of the successful completion of the Company's debt elimination transactions, compared to $104.3 million as of June 30, 2025." The 10-Q carries no substantial-doubt going-concern language: management says current working capital "will provide the Company with sufficient capital to fund operations for at least one year from the consolidated financial statement issuance date."

Underneath all of it, the operating business grew. Total revenue was $80,803 thousand against $64,286 thousand a year earlier. Product revenue did the work, at $53,871 thousand versus $37,535 thousand; service and subscription revenue was roughly flat at $24,668 thousand against $24,943 thousand, and royalties were $2,264 thousand against $1,808 thousand. Gross profit came in at $31,720 thousand, which the company puts at 39.3 percent of revenue; the same two lines a year earlier work out to about 35.3 percent. Operating expenses fell to $26,682 thousand from $35,308 thousand, with general and administrative expense down to $9,609 thousand from $13,569 thousand, sales and marketing at $11,027 thousand against $12,655 thousand, research and development at $6,023 thousand against $6,661 thousand, and restructuring charges of $23 thousand against $2,423 thousand.

Chief executive Hugues Meyrath framed the quarter in the release around the non-GAAP result and the order book. "Quantum delivered another strong quarter with revenue of approximately $81 million, above the high-end of our guidance, along with better-than-expected gross margin and EBITDA results. In addition, we delivered our first non-GAAP profitable quarter since 2023," he said, adding that "Our backlog also increased to record levels, reflecting continued robust demand for our tiered storage solutions as organizations confront explosive data growth, cost pressures and increasing power constraints." He flagged a constraint on the other side of the ledger: "Although supply constraints continue to limit our ability to fully meet demand, our growing revenue and backlog is clear evidence of order strength." On the recapitalization he said: "With the Company's debt eliminated and a strong cash position, we are operating from a position of financial strength and remain focused on procuring additional supply in support of our sales momentum and delivering sustainable growth and profitability." The claim of a first non-GAAP profitable quarter since 2023 is his; this newspaper has not independently verified the intervening quarters.

One more item sits between this quarter and the next one. The July 13 registration statement covers 13,809,707 shares for resale by existing holders — the 10,615,712 private placement shares, the 3,083,975 Share Consideration shares, and up to 110,020 shares issuable under the Conversion Warrant at its $5.00 floor exercise price. The first two blocks, 13,699,687 shares, already exist and already sit inside the share counts above; a resale registration creates no new dilution for them, it governs when the holders may sell into the market. The warrant shares are the exception — they are not outstanding and would be newly issued if the warrant were exercised. Against the 39,374,500 shares the prospectus reports outstanding as of July 1, the block of already-issued shares is about 35 percent of the company. What the next quarterly report will settle is narrower and more concrete: whether the weighted-average denominator resets to something near 39.4 million, whether the operating line stays above zero once the restructuring noise is gone, and whether the supply constraint the chief executive described eases enough to convert the backlog he called a record.

This article is for general information only and is not investment advice. Figures are as reported by the cited sources at time of writing.

Related coverage

Evolution Petroleum Prices $12 Million Stock Sale at $3.25 to Help Fund $16 Million Midland Basin Royalty Purchase
Small Caps

Evolution Petroleum Prices $12 Million Stock Sale at $3.25 to Help Fund $16 Million Midland Basin Royalty Purchase

The NYSE American-listed producer priced 3.7 million shares at $3.25 on Aug. 19, with closing expected Aug. 20, to part-fund roughly 3,420 net royalty acres in the Permian. Shares closed at $3.34, down 12.79% on the day.

Carter Whitfield · August 19, 2026
XTEND's European NATO Contract Is Valued at Up to $15 Million, With About $4.5 Million Secured for the First Year
Small Caps

XTEND's European NATO Contract Is Valued at Up to $15 Million, With About $4.5 Million Secured for the First Year

JFB Construction Holdings said Monday that XTEND, the drone maker it is merging with, signed a multi-year contract with an unnamed European NATO member's defense ministry. The release puts the ceiling at up to approximately $15 million and describes approximately $4.5 million as secured for the first year, with the balance dependent on additional orders and the customer exercising options under the framework agreement. It also moves the expected closing of the merger itself to Sept. 8, a week later than the date given six days earlier.

Carter Whitfield · August 18, 2026
NRx Says Its Ketamine Generic Cleared First-Cycle FDA Review With One Item Left — and Already Submitted. That Application Is the Anesthesia Label, Not Depression.
Small Caps

NRx Says Its Ketamine Generic Cleared First-Cycle FDA Review With One Item Left — and Already Submitted. That Application Is the Anesthesia Label, Not Depression.

NRx Pharmaceuticals told investors Monday afternoon that the FDA has finished first-cycle review of its generic ketamine filing, and that the one remaining item, a manufacturer's attestation on the vial, has already been sent to the agency. Monday's release never says what that filing covers; an earlier NRx release does — the drug's existing anesthesia label. The depression indication runs through a separate NRX-100 application the company said Monday it is still finalizing.

Ellis Vance · August 18, 2026